Congenericity of Claimed Compounds in Patent Applications

A method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a...

Full description

Bibliographic Details
Main Authors: Maria J. Falaguera, Jordi Mestres
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/17/5253
_version_ 1797521040932339712
author Maria J. Falaguera
Jordi Mestres
author_facet Maria J. Falaguera
Jordi Mestres
author_sort Maria J. Falaguera
collection DOAJ
description A method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a more diverse set of compounds around a more vaguely described patent claim. An application to 750 common patents available in SureChEMBL, SureChEMBLccs and ChEMBL is presented and the congenericity of patent compounds in those different sources discussed.
first_indexed 2024-03-10T08:07:04Z
format Article
id doaj.art-9f2693c6e5314d798147a08f62978af0
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T08:07:04Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-9f2693c6e5314d798147a08f62978af02023-11-22T11:01:23ZengMDPI AGMolecules1420-30492021-08-012617525310.3390/molecules26175253Congenericity of Claimed Compounds in Patent ApplicationsMaria J. Falaguera0Jordi Mestres1Research Group on Systems Pharmacology, Research Program on Biomedical Informatics (GRIB), IMIM Hospital del Mar Medical Research Institute, Parc de Recerca Biomèdica (PRBB), Doctor Aiguader 88, 08003 Barcelona, Catalonia, SpainResearch Group on Systems Pharmacology, Research Program on Biomedical Informatics (GRIB), IMIM Hospital del Mar Medical Research Institute, Parc de Recerca Biomèdica (PRBB), Doctor Aiguader 88, 08003 Barcelona, Catalonia, SpainA method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a more diverse set of compounds around a more vaguely described patent claim. An application to 750 common patents available in SureChEMBL, SureChEMBLccs and ChEMBL is presented and the congenericity of patent compounds in those different sources discussed.https://www.mdpi.com/1420-3049/26/17/5253chemical seriespatent compoundssimilarity analysisSureChEMBLSureChEMBLccsChEMBL
spellingShingle Maria J. Falaguera
Jordi Mestres
Congenericity of Claimed Compounds in Patent Applications
Molecules
chemical series
patent compounds
similarity analysis
SureChEMBL
SureChEMBLccs
ChEMBL
title Congenericity of Claimed Compounds in Patent Applications
title_full Congenericity of Claimed Compounds in Patent Applications
title_fullStr Congenericity of Claimed Compounds in Patent Applications
title_full_unstemmed Congenericity of Claimed Compounds in Patent Applications
title_short Congenericity of Claimed Compounds in Patent Applications
title_sort congenericity of claimed compounds in patent applications
topic chemical series
patent compounds
similarity analysis
SureChEMBL
SureChEMBLccs
ChEMBL
url https://www.mdpi.com/1420-3049/26/17/5253
work_keys_str_mv AT mariajfalaguera congenericityofclaimedcompoundsinpatentapplications
AT jordimestres congenericityofclaimedcompoundsinpatentapplications